Skip to content

The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Healthy Humans.

The Effect of High and Low Sodium Intake on Aquaporin-2 in Healthy Humans, During Basal Conditions and After Hypertonic Saline Infusion.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00345215
Enrollment
26
Registered
2006-06-27
Start date
2006-05-31
Completion date
2007-05-31
Last updated
2011-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Humans

Keywords

Urinary Aquaporin 2, High/low Sodium Diet, Fractional Sodium Excretion

Brief summary

The aim of the study is to test the hypothesis that the function and/or regulation of aquaporin 2 and/or endothelial sodium channels in the principal cells of healthy humans is abnormal at high and low sodium intake

Interventions

250-350 mmol

BEHAVIORALLow Sodium Diet

25-35 mmol

Sponsors

Regional Hospital Holstebro
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Caucasic men and women * Age 18-65 years * Body mass index less or equal to 30 Kg/m2

Exclusion criteria

* Arterial hypertension * History or clinical signs of heart, brain, lung, kidney, malignant or endocrine organ disease. * Abnormal biochemical screening of the blood regarding: red and white cell count, B-hemoglobin, P-sodium, P-potassium, P-creatinine, P-albumine, P- bilirubin, P-alanine aminotransferase, P- alkaline phosphatase, p-cholesterol and B-glucose. * Abnormal screening of the urine regarding: blood, albumine and glucose. * Alcohol or drug abuse * Drug use except oral contraceptives * Smoking * Abnormal electrocardiogram * Blood donation within one month of the first examination day * Pregnancy * Unwillingness to participate

Design outcomes

Primary

MeasureTime frame
u-AQP-2Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.
fractional sodium excretionBefore and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.
p-aldosteroneBefore and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.

Secondary

MeasureTime frame
u-ENaC(alfa-beta-gamma)Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.
uPGE2Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.
ucAMPBefore and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.
CH20Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.
GFRBefore and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.
u-pAQP-2Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026